APUS.................................................https://stockcharts.com/sc3/ui/?s=APUS&p=W&b=5&g=0&id=p86431144783
Recent APUS News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/26/2026 08:05:45 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2026 08:05:24 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 05/07/2026 01:11:47 PM
- Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program • Business Wire • 05/05/2026 06:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 04:30:34 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/04/2026 10:57:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 10:15:26 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2026 09:06:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/16/2026 08:30:16 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 04/09/2026 08:36:48 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/09/2026 08:30:08 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 08:57:02 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 03/30/2026 12:20:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:46:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 11:00:28 AM
- Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery • Business Wire • 03/24/2026 12:30:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 03/20/2026 10:21:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 08:30:33 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/17/2026 09:31:58 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:30:28 PM
- Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox) • Business Wire • 02/11/2026 09:51:00 PM
- Form PREM14C - Preliminary information statements relating to merger or acquisition • Edgar (US Regulatory) • 01/16/2026 09:35:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 09:30:52 PM
- Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy • Business Wire • 12/10/2025 02:58:00 PM
